Related Experiment Video
Updated: Nov 26, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Long non-coding RNA CDKN2B-AS1 regulates high glucose-induced human mesangial cell injury via regulating the
Jing Chang1, Yanming Yu2, Zhan Fang1
1Department of Nephrology, Yantaishan Hospital, Yantai, Shandong, China.
Background:
Long non-coding RNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) has been reported to be related to diabetic nephropathy (DN) progression. However, the regulatory mechanisms of CDKN2B-AS1 in DN are unclear.
Methods:
High glucose (HG) was used to induce human mesangial cells (HMCs) for establishing the DN model. Expression levels of CDKN2B-AS1, microRNA (miR)-15b-5p, wingless-Type family member 2B (WNT2B) mRNA in serum and HMCs were detected through quantitative real-time polymerase chain reaction (qRT-PCR). The viability and cell cycle progression of HMCs were determined with Cell Counting Kit-8 (CCK-8) or flow cytometry assays. The levels of several proteins and inflammatory factors in HMCs were analyzed by western blotting or enzyme-linked immunosorbent assay (ELISA). The relationship between CDKN2B-AS1 or WNT2B and miR-15b-5p was verified with dual-luciferase reporter assay.
Results:
CDKN2B-AS1 and WNT2B were upregulated while miR-15b-5p was downregulated in serum of DN patients and HG-treated HMCs. CDKN2B-AS1 inhibition reduced HG-induced viability, cell cycle progression, ECM accumulation, and inflammation response in HMCs. CDKN2B-AS1 regulated WNT2B expression via competitively binding to miR-15b-5p. MiR-15b-5p inhibitor reversed CDKN2B-AS1 knockdown-mediated influence on viability, cell cycle progression, ECM accumulation, and inflammation response of HG-treated HMCs. The repressive effect of miR-15b-5p mimic on viability, cell cycle progression, ECM accumulation, and inflammation response of HG-treated HMCs was abolished by WNT2B overexpression.
Conclusion:
CDKN2B-AS1 regulated HG-induced HMC viability, cell cycle progression, ECM accumulation, and inflammation response via regulating the miR-15b-5p/WNT2B axis, provided a new mechanism for understanding the development of DN.
Insights
Long non-coding RNA CDKN2B-AS1 promotes diabetic nephropathy by upregulating WNT2B via the miR-15b-5p pathway. This study reveals a novel mechanism in diabetic nephropathy development.
Area of Science:
- Molecular Biology
- Genetics
- Nephrology
Background:
- Diabetic nephropathy (DN) is a significant complication of diabetes.
- Long non-coding RNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) is implicated in DN progression.
- The precise regulatory mechanisms of CDKN2B-AS1 in DN remain largely unknown.
Purpose of the Study:
- To elucidate the role and regulatory mechanisms of CDKN2B-AS1 in high glucose-induced human mesangial cell (HMC) dysfunction.
- To investigate the interplay between CDKN2B-AS1, microRNA (miR)-15b-5p, and wingless-Type family member 2B (WNT2B) in the context of DN.
Main Methods:
- Established a DN model using high glucose (HG)-induced HMCs.
- Quantified expression levels of CDKN2B-AS1, miR-15b-5p, and WNT2B mRNA using qRT-PCR.
- Assessed HMC viability, cell cycle, ECM accumulation, and inflammation via CCK-8, flow cytometry, western blotting, and ELISA.
- Utilized dual-luciferase reporter assays to confirm interactions between CDKN2B-AS1, miR-15b-5p, and WNT2B.
Main Results:
- CDKN2B-AS1 and WNT2B were upregulated, while miR-15b-5p was downregulated in DN patients' serum and HG-treated HMCs.
- Inhibition of CDKN2B-AS1 ameliorated HG-induced HMC viability, cell cycle progression, ECM accumulation, and inflammation.
- CDKN2B-AS1 directly targeted miR-15b-5p, influencing WNT2B expression.
- MiR-15b-5p and WNT2B manipulations reversed the effects of CDKN2B-AS1 knockdown or overexpression, confirming the regulatory axis.
Conclusions:
- CDKN2B-AS1 exacerbates HG-induced HMC dysfunction through the miR-15b-5p/WNT2B pathway.
- This study provides a novel molecular mechanism underlying diabetic nephropathy development.
- Targeting the CDKN2B-AS1/miR-15b-5p/WNT2B axis may offer therapeutic strategies for DN.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Cell Specific Gene Expression
Canonical Wnt Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
lncRNA - Long Non-coding RNAs
cAMP-dependent Protein Kinase Pathways